These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 16388069)
1. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Frangou S; Lewis M; McCrone P Br J Psychiatry; 2006 Jan; 188():46-50. PubMed ID: 16388069 [TBL] [Abstract][Full Text] [Related]
2. Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Keck PE; Mintz J; McElroy SL; Freeman MP; Suppes T; Frye MA; Altshuler LL; Kupka R; Nolen WA; Leverich GS; Denicoff KD; Grunze H; Duan N; Post RM Biol Psychiatry; 2006 Nov; 60(9):1020-2. PubMed ID: 16814257 [TBL] [Abstract][Full Text] [Related]
3. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Keck PE; Versiani M; Potkin S; West SA; Giller E; Ice K; Am J Psychiatry; 2003 Apr; 160(4):741-8. PubMed ID: 12668364 [TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Calabrese JR; Keck PE; Macfadden W; Minkwitz M; Ketter TA; Weisler RH; Cutler AJ; McCoy R; Wilson E; Mullen J Am J Psychiatry; 2005 Jul; 162(7):1351-60. PubMed ID: 15994719 [TBL] [Abstract][Full Text] [Related]
5. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study. Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495 [TBL] [Abstract][Full Text] [Related]
6. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial. Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797 [TBL] [Abstract][Full Text] [Related]
7. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder. DelBello MP; Chang K; Welge JA; Adler CM; Rana M; Howe M; Bryan H; Vogel D; Sampang S; Delgado SV; Sorter M; Strakowski SM Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387 [TBL] [Abstract][Full Text] [Related]
8. Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial. Hirschfeld RM; Keck PE; Kramer M; Karcher K; Canuso C; Eerdekens M; Grossman F Am J Psychiatry; 2004 Jun; 161(6):1057-65. PubMed ID: 15169694 [TBL] [Abstract][Full Text] [Related]
9. Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression. Tohen M; McDonnell DP; Case M; Kanba S; Ha K; Fang YR; Katagiri H; Gomez JC Br J Psychiatry; 2012 Nov; 201(5):376-82. PubMed ID: 22918966 [TBL] [Abstract][Full Text] [Related]
10. Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study. Loebel A; Cucchiaro J; Silva R; Kroger H; Sarma K; Xu J; Calabrese JR Am J Psychiatry; 2014 Feb; 171(2):169-77. PubMed ID: 24170221 [TBL] [Abstract][Full Text] [Related]
11. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study. Vieta E; Calabrese JR; Goikolea JM; Raines S; Macfadden W; Bipolar Disord; 2007 Jun; 9(4):413-25. PubMed ID: 17547587 [TBL] [Abstract][Full Text] [Related]
12. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Sachs GS; Grossman F; Ghaemi SN; Okamoto A; Bowden CL Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192 [TBL] [Abstract][Full Text] [Related]
13. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies. Vieta E; Mullen J; Brecher M; Paulsson B; Jones M Curr Med Res Opin; 2005 Jun; 21(6):923-34. PubMed ID: 15969892 [TBL] [Abstract][Full Text] [Related]
14. Two 6-week, randomized, double-blind, placebo-controlled studies of ziprasidone in outpatients with bipolar I depression: did baseline characteristics impact trial outcome? Lombardo I; Sachs G; Kolluri S; Kremer C; Yang R J Clin Psychopharmacol; 2012 Aug; 32(4):470-8. PubMed ID: 22722504 [TBL] [Abstract][Full Text] [Related]